FibroGen Announces First Patient Dosed in ZEPHYRUS, a Phase 3 Clinical Trial of Pamrevlumab for the Treatment of Patients with Idiopathic Pulmonary Fibrosis

July 22, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search